Climb Bio Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:CLYM Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
22 Jul 24SellUS$988,495Valerie MorissetIndividual129,206US$8.07
18 Jul 24SellUS$289,492Valerie MorissetIndividual41,783US$6.93
16 Jul 24SellUS$356,500Valerie MorissetIndividual50,000US$7.13
15 Jul 24SellUS$650,563Valerie MorissetIndividual92,377US$7.07
11 Jul 24SellUS$736,500Valerie MorissetIndividual105,931US$7.11
05 Jul 24SellUS$87,135Valerie MorissetIndividual12,342US$7.06
03 Jul 24SellUS$286,293Valerie MorissetIndividual42,351US$6.76
27 Jun 24BuyUS$49,952,817RA Capital Management, L.P.Company13,008,546US$3.84

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of CLYM?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders491,5700.731%
General Public3,568,1755.31%
Private Companies5,009,4007.45%
Institutions26,735,34839.8%
VC/PE Firms31,419,26746.7%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 143.8%.


Top Shareholders

Top 25 shareholders own 92.07% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
46.7%
RA Capital Management, L.P.
31,419,267US$95.8m0%1.15%
7.45%
Ai Eti Llc
5,009,400US$15.3m0%no data
5.36%
Janus Henderson Group plc
3,606,495US$11.0m10.8%no data
3.88%
Samsara BioCapital LLC
2,609,114US$8.0m-20%1.15%
3.87%
Tavistock Life Sciences
2,603,190US$7.9m0%0.5%
3.23%
Deep Track Capital, LP
2,169,143US$6.6m-44.5%0.2%
2.98%
Intermediate Capital Group plc
2,002,563US$6.1m0%100.0%
2.78%
BlackRock, Inc.
1,867,097US$5.7m389%no data
2.27%
The Vanguard Group, Inc.
1,524,868US$4.7m367%no data
2.23%
Affinity Asset Advisors, LLC
1,500,000US$4.6m-10.2%0.78%
2.17%
LifeArc, Endowment Arm
1,461,538US$4.5m0%no data
1.83%
Ally Bridge Group
1,229,292US$3.7m146%1.34%
1%
T. Rowe Price Group, Inc.
672,566US$2.1m0%no data
0.97%
Geode Capital Management, LLC
651,297US$2.0m280%no data
0.91%
Driehaus Capital Management LLC
612,387US$1.9m-12%0.01%
0.88%
Point72 Asset Management, L.P.
590,946US$1.8m0%no data
0.69%
Pivotal BioVenture Partners LLC
463,654US$1.4m0%0.54%
0.47%
State Street Global Advisors, Inc.
315,036US$960.9k434%no data
0.44%
Northern Trust Global Investments
292,611US$892.5k541%no data
0.41%
Parkman Healthcare Partners LLC
278,775US$850.3k0%0.11%
0.37%
Great Point Partners, LLC
248,168US$756.9k0%0.27%
0.34%
Monashee Investment Management, LLC
230,000US$701.5k0%0.08%
0.27%
Sphera Funds Management Ltd
181,970US$555.0k-15.4%0.1%
0.26%
Adam Rosenberg
178,100US$543.2k0%no data
0.26%
Ikarian Capital, LLC
175,100US$534.0k75.1%0.15%